Logo image of EPRX

EUPRAXIA PHARMACEUTICALS INC (EPRX) Stock Analyst Ratings

NASDAQ:EPRX - Nasdaq - CA29842P1053 - Common Stock - Currency: USD

3.94  -0.03 (-0.76%)

Buy % Consensus

85

ChartMill assigns a Buy % Consensus number of 85% to EPRX. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 7.52. This target is 90.76% above the current price.
EPRX was analyzed by 8 analysts. The buy percentage consensus is at 85. So analysts seem to be very confident about EPRX.
In the previous month the buy percentage consensus was at a similar level.
EPRX was analyzed by 8 analysts. More opinions would make the average more meaningful.

Related screens

EPRX Historical Analyst RatingsEPRX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -24 -22 -20 -18 -16 -14 -12 -10 -8 -6 -4 -2 0 2 4 6 8

Price Target & Forecast

Price Low Median Mean High 3.946.067.527.529.17 - 53.91% 90.76% 90.76% 132.74%

Related screens

EPRX Current Analyst RatingEPRX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0
Up and Down Grades
Date Firm Action Rating
2024-11-14 Rodman & Renshaw Initiate Buy